The Antibody Shared Resource (ASR) is a dedicated high-throughput facility for antibody generation and related technologies. At the time of the last competitive renewal, this shared resource received an "Outstanding" rating. A major role for the ASR is to generate monoclonal (mAb) and polyclonal (pAb) antibodies and to make a broad range of antibody-related technologies cost effective and readily available to VICC investigators. For both mAb and pAb projects, the ASR offers end-to-end service that includes (1) antigen design, expression, and purification, (2) immunization and bleeding, and (3) protein-G (monoclonal) or antigen (polyclonal) affinity purification. Thus, investigators with no experience in the generation of antibodies can quickly and efficiently move a project forward. For monoclonal projects, ASR staff work closely with VICC investigators to ensure that the antibody screens are designed to capture antibodies tailored to their specific needs (e.g., immunoprecipitation, immunohistochemistry, receptor neutralization, etc). For polyclonal antibodies, aside from an initial consult, the ASR will handle the entire project, returning high quality affinity purified antibody. In addition, ASR staff provide a wide range of antibody support services including hybridoma subcloning, isotyping, ELISA screening, antibody scale up and large-scale production, antibody labeling (e.g., fluorophores, biotin, quantum dots, etc.), conjugation to affinity matrices (e.g., magnetic proteomic beads, sepharose), long-term hybridoma storage, and protein (antigen) design, expression, and purification. All shared resource services are offered at cost with rapid turnaround. Albert Reynolds, Ph.D., Professor of Cancer Biology with more than 20 years'experience with monoclonal antibody technology, directs this Resource as Scientific Director. Dr. Robert Carnahan, Research Assistant Professor of Cancer Biology, is the ASR Managing Director and oversees all aspects of daily operation. The staff is comprised of four technicians with specialized training in the full spectrum of services and methodologies provides by this resource.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
United States
Zip Code
Han, Ying; Signorello, Lisa B; Strom, Sara S et al. (2015) Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer 136:1210-7
Sanders, Melinda E; Schuyler, Peggy A; Simpson, Jean F et al. (2015) Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up. Mod Pathol 28:662-9
Chaturvedi, R; de Sablet, T; Asim, M et al. (2015) Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase. Oncogene 34:3429-40
Vilgelm, Anna E; Pawlikowski, Jeff S; Liu, Yan et al. (2015) Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells. Cancer Res 75:181-93
Wei, Jinxiong; Noto, Jennifer M; Zaika, Elena et al. (2015) Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut 64:1040-8
Carrillo, A M; Bouska, A; Arrate, M P et al. (2015) Mdmx promotes genomic instability independent of p53 and Mdm2. Oncogene 34:846-56
Weeke, Peter; Mosley, Jonathan D; Hanna, David et al. (2014) Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome. J Am Coll Cardiol 63:1430-7
Cheng, Feixiong; Jia, Peilin; Wang, Quan et al. (2014) Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. Mol Biol Evol 31:2156-69
Peng, Dun-Fa; Hu, Tian-Ling; Soutto, Mohammed et al. (2014) Loss of glutathione peroxidase 7 promotes TNF-?-induced NF-?B activation in Barrett's carcinogenesis. Carcinogenesis 35:1620-8
Troll, Christopher J; Adhikary, Suraj; Cueff, Marie et al. (2014) Interplay between base excision repair activity and toxicity of 3-methyladenine DNA glycosylases in an E. coli complementation system. Mutat Res 763-764:64-73

Showing the most recent 10 out of 1594 publications